Recent works focus on the role microRNAs (miRNAs) play in regulation of cardiovascular pathology. One of the miRNAs highly expressed in cardiovascular system is miR-21. The aim of this study was to investigate the relationship between the expression level of miR-21 in cardiac disease and correlate with TGF-b1, one of its targets.
Methods: Plasma samples from patients with CVD (cardiovascular diseases) established according to clinical and paraclinical exams were subjected to total RNAs isolation. miR-21 expression levels in patients with CVD and in healthy control subjects were quantified on ABI 7300 real-time PCR (Applied BioSystems) and normalized to RNU-43. TGF-b1 was predicted as potential target of miR-21 using MicroCosm TARGETS and quantified in TaqMan system (normalized to GAPDH). Statistical analysis was performed with GraphPad Prism.
Results: Significant lower levels of miR-21 were found in CVD patients vs. controls (p<0.0001). An inverse correlation between miR-21 and TGF-β1 expression levels was noted in CVD patients. miR-21 levels vs. control were significantly different for ATHE, CAD and ATH groups (p=0.0016, 0.0058 and 0.0032 respectively) and correlated with TGF-b1 expression and cardiac overload.
Conclusions: The results of this study suggest a good correlation between miR-21 and TGF-b1 in cardiovascular diseases.
Keywords: miR-21, TGF-b1, cardiovascular disease.
Full Text Sources:
Abstract:
Views: 871

Cited by 0 articles